ClinicalTrials.Veeva

Menu

Switching to E-cigarette After PCI (E-cig-PCI)

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Coronary Artery Disease

Treatments

Behavioral: Smoking cessation
Behavioral: Switching to E-cigarette

Study type

Observational

Funder types

Other

Identifiers

NCT06338761
E-cigarette PCI

Details and patient eligibility

About

Despite the increasing popularity of electronic cigarettes (E-cigarettes), the prognostic impact of switching to E-cigarettes in smokers with coronary artery disease (CAD) who underwent percutaneous coronary intervention (PCI) remains uncertain.

Full description

Recently, several studies have reported that, although lower than combustible cigarette users, E-cigarette users had a significantly higher risk of future myocardial infarction (MI) or cardiovascular disease compared with non-smokers or quitters. However, because all previous studies has focused on the general healthy population, these results cannot be extrapolated for patients who already proven atherosclerotic cardiovascular disease (ASCVD), such as undergoing percutaneous coronary intervention (PCI) for coronary artery disease (CAD). Although Busch et al. previously reported that a significant minority of patients are using E-cigarettes post-acute coronary syndrome smokers, a paucity of data exists regarding the impact of such transitions on clinical outcomes in current smoker patients with CAD who have undergone PCI. In light of these considerations, the current study sought to address this gap in knowledge by evaluating the prognostic implications of smoking habit changes, including E-cigarette use, among CAD patients with current smoking status following PCI.

Enrollment

17,973 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients who underwent health screening 3 years before and after the PCI

Exclusion criteria

  • history of cancer
  • history of ischemic stroke
  • died within the first 3 months of follow-up from the index date
  • Newly developed acute MI or received additional PCI or CABG from the index PCI date to the study index date

Trial design

17,973 participants in 3 patient groups

Continued combustible cigarette use
Description:
continued combustible cigarettes users after PCI
Switching to E-cigarette
Description:
switching to E-cigarette users after PCI
Treatment:
Behavioral: Switching to E-cigarette
Quitter
Description:
quitters after PCI
Treatment:
Behavioral: Smoking cessation

Trial contacts and locations

1

Loading...

Central trial contact

Ki Hong Choi; Danbee Kang, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems